Hints and tips:
Related Special Reports
...WPP’s Ogilvy advertising agency is creating a division specialising in online “health influencers” to help pharmaceutical companies tap a trend towards personalised health and combat misinformation....
...Two Humira biosimilars — from Organon in collaboration with Samsung Bioepis and Teva Pharmaceuticals working with Alvotech — earlier this year became the first to be granted interchangeable status by the...
Admonitions about staff trading in their employer’s shares may now need to be broadened
...The case is the latest in a series of intellectual property battles that companies are fighting around the world over mRNA technology, which has helped generate billions in revenues for the pharmaceuticals...
...If the total rose above this threshold, companies had to pay back money through a levy....
A company launched in 1963 confronts challenge of adapting to the rise of anti-obesity injections
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
US healthcare company is putting cash to work from spinning off its consumer health arm
Shah Capital wants change in US biotech’s strategy as its shares have tumbled since their pandemic peak
...As things stand, the government pays 80 per cent of the “catastrophic” coverage when costs balloon beyond a threshold — $11,206 in 2023....
...Avid Bioservices, a small-cap company that helps develop and manufacture drugs for pharmaceutical companies, filed this with the SEC yesterday: On February 29, 2024, Avid Bioservices, Inc....
Advocate general of bloc’s top court says decision against world’s biggest gene sequencing group should be annulled
A weight loss titan fights to stay relevant in the age of GLP-1 drugs
...Pharmaceuticals groups Pfizer and Moderna, which have both faced criticism from fringe groups over their Covid-19 vaccines, also spent heavily on security for their CEOs last year....
...Other executives also had compensation potentially worth millions tied to the threshold....
...The Medicines and Healthcare products Regulatory Agency has approved the therapy, called Casgevy, which was developed by Vertex Pharmaceuticals and Crispr Therapeutics....
...Companies whose products breached that threshold would be required to pay rebates to Medicare, the publicly funded health insurance for seniors....
...Despite splashing out nearly $55bn on two major acquisitions over the past two years, the pharmaceutical company is worth less than it was before the pandemic....
...Unless there are other banks that have passed the $100bn threshold and also specialise in NYC regulated multifamily buildings, all of this looks non-transferable....
US drugmaker is trying to chart its future without blockbuster Covid-19 products
...“To this day, OpenAI, Inc.’s website continues to profess that its charter is to ensure that AGI ‘benefits all of humanity’,” it adds....
...Recent launches from JPMorgan and State Street Global Advisors have all reached the $10bn threshold in about two years, according to Morningstar....
...Rival pharmaceutical groups are eager to enter the market, including AstraZeneca, which recently signed a licensing deal with Chinese company Eccogene for the rights to its weight loss pill....
Millions of Paxlovid pills have gone unused as tight controls restrict access
...Higher fee levels are set to kick in several months down the line, or once an ETF reaches a certain asset value threshold — with the exception of Grayscale Investments’ bitcoin ETF, which maintains a hefty...
International Edition